Q2 2023 Holdings
Filed 2023-08-14 | 8 holdings | $203.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-09-07) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc.(TRDA) | Common | 29384C108 | $67.0M | 4,425,784 | 32.9% |
| Dyne Therapeutics, Inc.(DYN) | Common | 26818M108 | $55.7M | 4,951,303 | 27.3% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $36.3M | 2,738,785 | 17.8% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $23.7M | 2,242,636 | 11.6% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $13.1M | 4,284,172 | 6.4% |
| Adaptimmune Therapeutics plc(ADAPY) | Common | 00653A107 | $5.8M | 6,287,101 | 2.9% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $2.2M | 3,131,388 | 1.1% |
| Oncorus, Inc. | Common | 68236R103 | $115.4K | 2,849,464 | 0.1% |